Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4 (original) (raw)

References

• Adnane J, Gaudray P, Dionne CA, Crumley G, Jaye M, Schlessinger J, Jeanteur P, Birnbaum D and Theillet C. . 1991 Oncogene 6: 659–663.
• Baik MG, Lee MJ and Choi YJ. . 1998 Int. J. Mol. Med. 2: 39–44.
• Basilico C and Moscatelli D. . 1992 Advan. Cancer Res. 59: 115–165.
• Bates SE, Davidson SE, Valverius EM, Dickson RB, Freter CE, Tam JP, Kudlow JE, Lippman ME and Salomon DS. . 1988 Mol. Endocrinol. 2: 543–555.
• Brustle O, Aguzzi A, Talarico D, Basilico C, Kleihues P and Wiestler OD. . 1992 Oncogene 7: 1177–1183.
• Chodosh LA, Gardner HP, Rajan JV, Stairs DB, Marquis ST and Leder PA. . 2000 Dev. Biol. 219: 259–276.
• Chomczynski P and Sacchi N. . 1987 Anal. Biochem. 162: 156–159.
• Coleman-Krnacik S and Rosen JM. . 1994 Mol. Endocrinol. 8: 218–229.
• Daphna-Iken D, Shankar DB, Lawshé A, Ornitz DM, Shackleford GM and MacArthur CA. . 1998 Oncogene 17: 2711–2717.
• Delli-Bovi P, Curatola AM, Kern FG, Greco A, Ittman M and Basilico C. . 1987 Cell 50: 729–737.
• Deroanne CF, Hajitou A, Calberg-Bacq CM, Nusgens BV and Lapière CM. . 1997 Cancer Res. 57: 5590–5597.
• Dickson C, Smith R, Brookes S and Peters G. . 1984 Cell 37: 529–536.
• Dickson RB, Gottardis MM and Merlino GT. . 1991 BioEssays 13: 591–596.
• Fantl V, Stamo G, Andrews A, Rosewell I and Dickson C. . 1995 Genes Dev. 9: 2364–2372.
• Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK and Seed B. . 1998 Cell 94: 715–725.
• Gavin B and McMahon A. . 1992 Mol. Cell. Biol. 12: 2418–2423.
• Hajitou A, Deroanne C, Noel A, Collette J, Nusgens B, Foidart JM and Calberg-Bacq CM. . 2000 Breast Cancer Res. Treat. 60: 15–28.
• Hennighausen L and Robinson GW. . 1998 Genes Dev. 12: 449–455.
• Hogan B, Beddington R, Costantini F and Lacy E. . 1994 Manipulating the Mouse Embryo: a Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
  Google Scholar
• Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyrhonen S, Lehtovirta P and Nevanlinna H. . 1993 Int. J. Cancer 54: 378–382.
• Jackson D, Bresnick J, Rosewell I, Crafton T, Poulsom R, Stamp G and Dickson C. . 1997 J. Cell Sci. 110: 1261–1268.
• Johnson MR, Valentine C, Basilico C and Mansukhani A. . 1998 Oncogene 16: 2647–2656.
• Kitsberg DI and Leder P. . 1996 Oncogene 13: 2507–2515.
• Kiuru-Kukuhlefelt S, Sarlomo-Rikala M, Larramendy ML, Soderlund M, Hedman K, Miettinen M and Knuutila S. . 2000 Mol. Pathol. 13: 433–437.
• Labosky PA, Winnier GE, Jetton TL, Hargett L, Ryan AK, Rosenfeld MG, Parlow AF and Hogan BLM. . 1997 Development 124: 1263–1274.
• MacArthur CA, Shankar DB and Shackleford GM. . 1995 J. Virol. 69: 2501–2507.
• Mangiarini L, Sathasivam K, Seller M, Cozens B, Haper A, Hetherington C, Lawton M, Trottier Y, Lehrac H, Davies SW and Bates GP. . 1996 Cell 87: 493–506.
• McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB and Kern FG. . 1993 Cancer Res. 53: 2168–2177.
• Merlo GR, Vanesio T, Taverna D, Marte BM, Callahan R and Hynes NE. . 1994 Oncogene 9: 443–453.
• Muller WJ, Lee FS, Dickson C, Peters G, Pattengale P and Leder P. . 1990 EMBO J. 9: 907–913.
• Murphy LJ, Sutherland RL, Steed B, Murphy LC and Lazarus L. . 1986 Mol. Endocrinol. 46: 4555–4560.
• Neuenschwander S, Schwartz A, Wood TL, Roberts Jr CT, Henninghausen L and LeRoith D. . 1996 J. Clin. Invest. 97: 2225–2232.
• Oberhammer F, Fritsch G, Schmied M, Pavelka M, Printz D, Purchio T, Lassmann H and Schult-Hermann R. . 1993 J. Cell Sci. 104: 317–326.
• Ornitz DM, Moreadith RW and Leder P. . 1991 Proc. Natl. Acad. Sci. USA 88: 698–702.
• Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G and Goldfarb M. . 1996 J. Biol. Chem. 271: 15292–15297.
• Payson RA, Wu J, Liu Y and Chiu IM. . 1996 Oncogene 13: 47–53.
• Panault-Llorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J, Birnbaum D and Delapeyriere O. . 1995 Int. J. Cancer 61: 170–176.
• Peters G, Brookes S, Smith R, Placzek M and Dickson C. . 1989 Proc. Natl. Acad. Sci. USA 86: 5678–5682.
• Pittius CW, Sankaran L, Topper YJ and Hennighausen L. . 1988 Mol. Endocrin. 2: 1027–1032.
• Quarto N, Talarico D, Sommer A, Florkiewicz R, Basilico C and Rifkin DB. . 1989 Oncogene Res. 5: 101–110.
• Robinson GW, McKnight RA, Smith GH and Hennighausen L. . 1995 Development 121: 2079–2090.
• Shackleford GM, MacArthur CA, Kwan HC and Varmus HE. . 1993 Proc. Natl. Acad. Sci. USA 90: 740–744.
• Shimon I, Huttner A, Said J, Spirina OM and Melmed S. . 1996 J. Clin. Invest. 97: 187–195.
• Shimon I, Hinton DR, Weiss MH and Melmed S. . 1998 Clin. Endocrinol. 48: 23–29.
• Souttou B, Gamby C, Crepin M and Hamelin R. . 1996 Int. J. Cancer 68: 675–681.
• Talarico D, Ittmann MM, Bronson R and Basilico C. . 1993 Mol. Cell. Biol. 13: 1998–2010.
• Taylor WR, Greenberg AH, Turley EA and Wright JA. . 1993 Exp. Cell Res. 204: 295–301.
• Theillet C, Le Roy X, De Lapeyriere O, Grosgeorges J, Adnane J, Raynaud SD, Simony-Lafontaine J, Goldfarb M, Escot C and Birnbaum D. . 1989 Oncogene 4: 915–922.
• Vaahtokari A, Aberg T and Thesleff I. . 1996 Development 122: 121–129.
• Yiangou C, Gomm JJ, Coope RC, Law M, Luqmani Y, Shousha S, Coombes RC and Johnston CL. . 1997 Br. J. Cancer 75: 28–33.

Download references